This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kearney, M.
Right arrow Articles by Palmer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kearney, M.
Right arrow Articles by Palmer, S.

 Previous Article  |  Next Article 

Journal of Virology, March 2009, p. 2715-2727, Vol. 83, No. 6
0022-538X/09/$08.00+0     doi:10.1128/JVI.01960-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals{triangledown} ,{dagger}

M. Kearney,1,2* F. Maldarelli,1 W. Shao,3 J. B. Margolick,4 E. S. Daar,5 J. W. Mellors,6 V. Rao,2 J. M. Coffin,7 and S. Palmer1,{ddagger}

HIV Drug Resistance Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland,1 Department of Biology, Catholic University of America, Washington, D.C.,2 Advanced Biomedical Computing Center, SAIC, Frederick, Maryland,3 Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland,4 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California,5 Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania,6 Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts7

Received 17 September 2008/ Accepted 22 December 2008

Studies on human immunodeficiency virus type 1 (HIV-1) diversity are critical for understanding viral pathogenesis and the emergence of immune escape variants and for design of vaccine strategies. To investigate HIV-1 population genetics, we used single-genome sequencing to obtain pro-pol and env sequences from longitudinal samples (n = 93) from 14 acutely or recently infected patients. The first available sample after infection for 12/14 patients revealed HIV-1 populations with low genetic diversity, consistent with transmission or outgrowth of a single variant. In contrast, two patients showed high diversity and coexistence of distinct virus populations in samples collected days after a nonreactive enzyme-linked immunosorbent assay or indeterminate Western blot, consistent with transmission or outgrowth of multiple variants. Comparison of PR and RT sequences from the first sample for all patients with the consensus subgroup B sequence revealed that nearly all nonsynonymous differences were confined to identified cytotoxic T-lymphocyte (CTL) epitopes. For HLA-typed patients, mutations compared to the consensus in transmitted variants were found in epitopes that would not be recognized by the patient's major histocompatibility complex type. Reversion of transmitted mutations was rarely seen over the study interval (up to 5 years). These data indicate that acute subtype B HIV-1 infection usually results from transmission or outgrowth of single viral variants carrying mutations in CTL epitopes that were selected prior to transmission either in the donor or in a previous donor and that reversion of these mutations can be very slow. These results have important implications for vaccine strategies because they imply that some HLA alleles could be compromised in newly acquired HIV infections.


* Corresponding author. Mailing address: HIV Drug Resistance Program, National Cancer Institute at Frederick, 1050 Boyles Street, Building 535, Room 109, Frederick, MD 21702-1201. Phone: (301) 846-6796. Fax: (301) 846-6013. E-mail: kearneym{at}ncifcrf.gov

{triangledown} Published ahead of print on 30 December 2008.

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/.

{ddagger} Present address: Swedish Institute for Infectious Disease Control, Karolinska Institute, Stockholm, Sweden.


Journal of Virology, March 2009, p. 2715-2727, Vol. 83, No. 6
0022-538X/09/$08.00+0     doi:10.1128/JVI.01960-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Salazar-Gonzalez, J. F., Salazar, M. G., Keele, B. F., Learn, G. H., Giorgi, E. E., Li, H., Decker, J. M., Wang, S., Baalwa, J., Kraus, M. H., Parrish, N. F., Shaw, K. S., Guffey, M. B., Bar, K. J., Davis, K. L., Ochsenbauer-Jambor, C., Kappes, J. C., Saag, M. S., Cohen, M. S., Mulenga, J., Derdeyn, C. A., Allen, S., Hunter, E., Markowitz, M., Hraber, P., Perelson, A. S., Bhattacharya, T., Haynes, B. F., Korber, B. T., Hahn, B. H., Shaw, G. M. (2009). Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. JEM 206: 1273-1289 [Abstract] [Full Text]  
  • Keele, B. F., Li, H., Learn, G. H., Hraber, P., Giorgi, E. E., Grayson, T., Sun, C., Chen, Y., Yeh, W. W., Letvin, N. L., Mascola, J. R., Nabel, G. J., Haynes, B. F., Bhattacharya, T., Perelson, A. S., Korber, B. T., Hahn, B. H., Shaw, G. M. (2009). Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. JEM 206: 1117-1134 [Abstract] [Full Text]